Privia Health Group, Inc. Financing Cash Flow
Privia Health Group, Inc. (PRVA) reported Financing Cash Flow of -$7.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- Privia Health Group, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $3.04M, a 61.39% increase year-over-year.
- Privia Health Group, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$10.67M, a 575.70% decline year-over-year.
- Privia Health Group, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $2.15M, a 246.53% increase year-over-year.
- Privia Health Group, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $431.00K, a 71.09% decline year-over-year.
- Privia Health Group, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $6.70M, a 54.64% increase from fiscal 2024.
- Privia Health Group, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $4.33M, a 16.98% increase from fiscal 2023.
- Privia Health Group, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $3.71M.
- Privia Health Group, Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$19.68M, a 109.21% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$7.63M 10-Q · filed 2026-08-06 | -$5.49M derived: sum of 3 quarters · filed 2026-08-06 | -$5.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$10.67M 10-Q · filed 2026-05-07 | -$8.53M derived: sum of 2 quarters · filed 2026-05-07 | -$8.09M derived: sum of 3 quarters · filed 2026-05-07 | -$6.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.58M derived: sum of 2 quarters · filed 2026-02-27 | $4.46M derived: sum of 3 quarters · filed 2026-08-06 | $6.70M 10-K · filed 2026-02-27 |
| 2025-09-30 | $431.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.31M derived: sum of 2 quarters · filed 2026-08-06 | $4.56M 10-Q · filed 2025-11-06 | $5.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.13M 10-Q · filed 2026-08-06 | $4.75M derived: sum of 3 quarters · filed 2026-08-06 | $6.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.24M 10-Q · filed 2026-05-07 | $2.86M derived: sum of 2 quarters · filed 2026-05-07 | $4.35M derived: sum of 3 quarters · filed 2026-05-07 | $6.10M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $619.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.11M derived: sum of 2 quarters · filed 2026-02-27 | $3.86M derived: sum of 3 quarters · filed 2026-02-27 | $4.33M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.24M derived: sum of 2 quarters · filed 2025-11-06 | $3.71M 10-Q · filed 2025-11-06 | $3.76M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.22M 10-Q · filed 2025-08-07 | $2.27M derived: sum of 3 quarters · filed 2026-02-27 | $5.27M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $475.00K 10-Q · filed 2025-05-08 | $517.00K derived: sum of 2 quarters · filed 2026-02-27 | $3.52M derived: sum of 3 quarters · filed 2026-02-27 | $2.70M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.05M derived: sum of 2 quarters · filed 2026-02-27 | $2.23M derived: sum of 3 quarters · filed 2026-02-27 | $3.71M 10-K · filed 2026-02-27 |
| 2023-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.19M derived: sum of 2 quarters · filed 2024-11-07 | $3.66M 10-Q · filed 2024-11-07 | $5.62M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$819.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $658.00K 10-Q · filed 2024-08-08 | $2.62M derived: sum of 3 quarters · filed 2025-02-27 | $11.19M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.48M 10-Q · filed 2024-05-09 | $3.43M derived: sum of 2 quarters · filed 2025-02-27 | $12.01M derived: sum of 3 quarters · filed 2025-02-27 | -$18.91M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $10.53M derived: sum of 2 quarters · filed 2025-02-27 | -$20.38M derived: sum of 3 quarters · filed 2025-02-27 | -$19.68M 10-K · filed 2025-02-27 |
| 2022-09-30 | $8.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$22.34M derived: sum of 2 quarters · filed 2023-11-03 | -$21.63M 10-Q · filed 2023-11-03 | -$18.47M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$30.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$30.21M 10-Q · filed 2023-08-03 | -$27.04M derived: sum of 3 quarters · filed 2024-02-27 | -$27.14M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $705.00K 10-Q · filed 2023-05-04 | $3.87M derived: sum of 2 quarters · filed 2024-02-27 | $3.78M derived: sum of 3 quarters · filed 2024-02-27 | $214.59M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $3.07M derived: sum of 2 quarters · filed 2024-02-27 | $213.88M derived: sum of 3 quarters · filed 2024-02-27 | $213.66M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $210.72M derived: sum of 2 quarters · filed 2022-11-10 | $210.50M 10-Q · filed 2022-11-10 | $210.28M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $210.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $210.59M 10-Q · filed 2022-08-11 | $210.37M derived: sum of 3 quarters · filed 2023-03-01 | $200.26M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$219.00K 10-Q · filed 2022-05-12 | -$438.00K derived: sum of 2 quarters · filed 2023-03-01 | -$10.55M derived: sum of 3 quarters · filed 2023-03-01 | -$10.99M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$10.33M derived: sum of 2 quarters · filed 2023-03-01 | -$10.77M derived: sum of 3 quarters · filed 2023-03-01 | -$767.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | -$10.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$10.55M derived: sum of 2 quarters · filed 2021-11-08 | -$548.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | -$438.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $9.56M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $10.00M 10-Q · filed 2021-05-28 | |||
| 2019-12-31 | -$10.87M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |